GTHP logo

Guided Therapeutics, Inc. Stock Price

OTCPK:GTHP Community·US$30.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GTHP Share Price Performance

US$0.36
0.21 (140.00%)
US$0.36
0.21 (140.00%)
Price US$0.36

GTHP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with weak fundamentals.

7 Risks
0 Rewards

Guided Therapeutics, Inc. Key Details

US$178.0k

Revenue

US$67.0k

Cost of Revenue

US$111.0k

Gross Profit

US$2.9m

Other Expenses

-US$2.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.033
62.36%
-1,575.28%
-41.5%
View Full Analysis

About GTHP

Founded
1992
Employees
4
CEO
Mark Faupel
WebsiteView website
www.guidedinc.com

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.

Recent GTHP News & Updates

Recent updates

No updates